Revasum, Inc. announced earnings results for the full year ended January 3, 2021. For the full year, the company announced sales was USD 15.368 million compared to USD 20.507 million a year ago. Operating loss was USD 8.927 million compared to USD 14.919 million a year ago. Net loss was USD 9.156 million compared to USD 14.946 million a year ago. Basic loss per share from continuing operations was USD 0.12 compared to USD 0.19 a year ago.